
India and Panacea Biotec will collaborate on the development of Betacoronavirus vaccines
Indian government and pharmaceutical company Panacea Biotec launched a collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to explore vaccine candidates that could provide wide protection against SARS-COV-2 variations and other Betacoronaviruses.